Solid-phase extraction and optimized separation of doxorubicin, epirubicin and their metabolites using reversed-phase high-performance liquid chromatography
- 1 October 1992
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 10 (10-12) , 949-957
- https://doi.org/10.1016/0731-7085(91)80104-h
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Method for Analysis, and Distribution Profile, of Covalently-linked Ferritin-daunorubicin Conjugate in the Blood of Trypanosome-infected MiceJournal of Pharmacy and Pharmacology, 1992
- HPLC determination of doxorubicin, doxorubicinol and four aglycone metabolites in plasma of AIDS patientsJournal of Pharmaceutical and Biomedical Analysis, 1991
- High-performance liquid chromatographic bioanalysis of anthracycline cytostatic drugsJournal of Pharmaceutical and Biomedical Analysis, 1988
- Estimation of doxorubicin and doxorubicinol by high-performance liquid chromatography and advanced automated sample processorJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Improved method for the determination of 4′-epidoxorubicin and seven metabolites in plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Rapid high-performance liquid chromatographic assay for the anthracyclines daunorubicin and 7-con-O-methylnogarol in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- The Anthracycline Antineoplastic DrugsNew England Journal of Medicine, 1981
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979
- Classification off the Solvent Properties of Common LiquidsJournal of Chromatographic Science, 1978
- A Simplex Method for Function MinimizationThe Computer Journal, 1965